HEADER SIGNALING PROTEIN 08-JUL-98 1NF1 TITLE THE GAP RELATED DOMAIN OF NEUROFIBROMIN CAVEAT 1NF1 RESIDUE LEU 1486 HAS CHIRALITY PROBLEM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (NEUROFIBROMIN); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GAP RELATED DOMAIN; COMPND 5 SYNONYM: NF1-333; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: SEE REF.5 FOR DETAILS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: CYTOSOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DG103; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET-3D PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PTRC99A; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PETNF1-333; SOURCE 12 OTHER_DETAILS: S. REF. 4 KEYWDS NEUROFIBROMIN, TYPE I NEUROFIBROMATOSIS, NF1, RAS, GAP, SIGNAL KEYWDS 2 TRANSDUCTION, CANCER, GROWTH REGULATION, GTP HYDROLYSIS, PATIENT KEYWDS 3 MUTATION, ARGININE FINGER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.SCHEFFZEK,M.R.AHMADIAN,L.WIESMUELLER,W.KABSCH,P.STEGE,F.SCHMITZ, AUTHOR 2 A.WITTINGHOFER REVDAT 6 27-DEC-23 1NF1 1 REMARK REVDAT 5 04-OCT-17 1NF1 1 REMARK REVDAT 4 24-FEB-09 1NF1 1 VERSN REVDAT 3 01-APR-03 1NF1 1 JRNL REVDAT 2 05-MAY-00 1NF1 1 REMARK DBREF CAVEAT REVDAT 1 20-JUL-99 1NF1 0 JRNL AUTH K.SCHEFFZEK,M.R.AHMADIAN,L.WIESMULLER,W.KABSCH,P.STEGE, JRNL AUTH 2 F.SCHMITZ,A.WITTINGHOFER JRNL TITL STRUCTURAL ANALYSIS OF THE GAP-RELATED DOMAIN FROM JRNL TITL 2 NEUROFIBROMIN AND ITS IMPLICATIONS. JRNL REF EMBO J. V. 17 4313 1998 JRNL REFN ISSN 0261-4189 JRNL PMID 9687500 JRNL DOI 10.1093/EMBOJ/17.15.4313 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.SCHEFFZEK,M.R.AHMADIAN,W.KABSCH,L.WIESMUELLER,A.LAUTWEIN, REMARK 1 AUTH 2 F.SCHMITZ,A.WITTINGHOFER REMARK 1 TITL THE RAS-RASGAP COMPLEX: STRUCTURAL BASIS FOR GTPASE REMARK 1 TITL 2 ACTIVATION AND ITS LOSS IN ONCOGENIC RAS MUTANTS REMARK 1 REF SCIENCE V. 277 333 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 DOI 10.1126/SCIENCE.277.5324.333 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.R.AHMADIAN,P.STEGE,K.SCHEFFZEK,A.WITTINGHOFER REMARK 1 TITL CONFIRMATION OF THE ARGININE-FINGER HYPOTHESIS FOR THE REMARK 1 TITL 2 GAP-STIMULATED GTP- HYDROLYSIS REACTION OF RAS REMARK 1 REF NAT.STRUCT.BIOL. V. 4 686 1997 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.R.AHMADIAN,L.WIESMUELLER,A.LAUTWEIN,F.R.BISCHOFF, REMARK 1 AUTH 2 A.WITTINGHOFER REMARK 1 TITL STRUCTURAL DIFFERENCES IN THE MINIMAL CATALYTIC DOMAINS OF REMARK 1 TITL 2 THE GTPASSE- ACTIVATING PROTEINS P120GAP AND NEUROFIBROMIN REMARK 1 REF J.BIOL.CHEM. V. 271 16409 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.271.27.16409 REMARK 1 REFERENCE 4 REMARK 1 AUTH K.SCHEFFZEK,A.LAUTWEIN,W.KABSCH,M.R.AHMADIAN,A.WITTINGHOFER REMARK 1 TITL 3-DIMENSIONAL STRUCTURE OF THE GTPASE ACTIVATING DOMAIN OF REMARK 1 TITL 2 HUMAN P120GAP AND IMPLICATIONS FOR THE INTERACTION WITH RAS REMARK 1 REF NATURE V. 384 591 1996 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/384591A0 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.MITTAL,M.R.AHMADIAN,R.S.GOODY,A.WITTINGHOFER REMARK 1 TITL FORMATION OF A TRANSITION-STATE ANALOG OF THE RAS GTPASE REMARK 1 TITL 2 REACTION BY RAS:GDP, TETRAFLUOROALUMINATE AND REMARK 1 TITL 3 GTPASE-ACTIVATING PROTEINS REMARK 1 REF SCIENCE V. 273 115 1996 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 6 REMARK 1 AUTH D.H.GUTMANN,F.S.COLLINS REMARK 1 TITL THE NEUROFIBROMATOSIS TYPE I GENE AND ITS PROTEIN PRODUCT REMARK 1 REF NEURON V. 10 335 1993 REMARK 1 REFN ISSN 0896-6273 REMARK 1 REFERENCE 7 REMARK 1 AUTH R.BALLESTER,D.MARCHUK,M.BOGUSKI,A.SAULINO,R.LETCHER, REMARK 1 AUTH 2 M.WIGLER,F.COLLINS REMARK 1 TITL THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO REMARK 1 TITL 2 MAMMALIAN GAP AND YEAST IRA PROTEINS REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 63 851 1990 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(90)90151-4 REMARK 1 REFERENCE 8 REMARK 1 AUTH G.A.MARTIN,D.VISKOCHIL,G.BOLLAG,P.C.MCCABE,W.J.CROSIER, REMARK 1 AUTH 2 H.HAUSBRUCK,L.CONROY,R.CLARK,P.O'CONNELL,R.M.CAWTHON, REMARK 1 AUTH 3 M.A.INNIS,F.MCCORMICK REMARK 1 TITL THE GAP-RELATED DOMAIN OF THE NEUROFIBROMATOSIS TYPE I GENE REMARK 1 TITL 2 PRODUCT INTERACTS WITH RAS P21 REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 63 843 1990 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(90)90150-D REMARK 1 REFERENCE 9 REMARK 1 AUTH G.XU,B.LIN,K.TANAKA,D.DUNN,D.WOD,R.GESTELAND,R.WHITE, REMARK 1 AUTH 2 R.WEISS,F.TAMANOI REMARK 1 TITL THE CATALYTIC DOMAIN OF THE NEUROFIBROMATOSIS TYPE I GENE REMARK 1 TITL 2 PRODUCT STIMULATES RAS GTPASE AND COMPLEMENTS IRA MUTANTS OF REMARK 1 TITL 3 S. CEREVISIAE REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 63 835 1990 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(90)90149-9 REMARK 1 REFERENCE 10 REMARK 1 AUTH E.F.PAI,U.KRENGEL,G.A.PETSKO,R.S.GOODY,W.KABSCH, REMARK 1 AUTH 2 A.WITTINGHOFER REMARK 1 TITL REFINED CRYSTAL STRUCTURE OF THE TRIPHOSPHATE CONFORMATION REMARK 1 TITL 2 OF H-RAS P21 AT 1.35 A RESOLUTION: IMPLICATIONS FOR THE REMARK 1 TITL 3 MECHANISM OF GTP HYDROLYSIS REMARK 1 REF EMBO J. V. 9 2351 1990 REMARK 1 REFN ISSN 0261-4189 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 10926 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.266 REMARK 3 FREE R VALUE : 0.369 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1152 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1058 REMARK 3 BIN R VALUE (WORKING SET) : 0.4000 REMARK 3 BIN FREE R VALUE : 0.4360 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 11.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1948 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.53 REMARK 3 LOW RESOLUTION CUTOFF (A) : 30.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.58 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.54 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.070 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.020 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.610 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.590 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED IN FINAL STAGES REMARK 4 REMARK 4 1NF1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-99. REMARK 100 THE DEPOSITION ID IS D_1000001210. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-97 REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 6 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS (W.KABSCH) REMARK 200 DATA SCALING SOFTWARE : XSCALE (KABSCH) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50172 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MULTIPLE ISOMORPHOUS REMARK 200 REPLACEMENT REMARK 200 SOFTWARE USED: PROGRAM SUITE BY W. KABSCH REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: S. REF. DESCRIBING THE STRUCTURE, PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.12500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.12500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1198 REMARK 465 THR A 1199 REMARK 465 VAL A 1200 REMARK 465 LEU A 1201 REMARK 465 ALA A 1202 REMARK 465 ASP A 1203 REMARK 465 ARG A 1204 REMARK 465 PHE A 1205 REMARK 465 LEU A 1305 REMARK 465 ARG A 1306 REMARK 465 ILE A 1307 REMARK 465 VAL A 1308 REMARK 465 ILE A 1309 REMARK 465 THR A 1310 REMARK 465 SER A 1311 REMARK 465 SER A 1312 REMARK 465 ASP A 1313 REMARK 465 TRP A 1314 REMARK 465 GLN A 1315 REMARK 465 HIS A 1316 REMARK 465 VAL A 1317 REMARK 465 SER A 1318 REMARK 465 PHE A 1319 REMARK 465 GLU A 1320 REMARK 465 VAL A 1321 REMARK 465 ASP A 1322 REMARK 465 PRO A 1323 REMARK 465 THR A 1324 REMARK 465 ARG A 1325 REMARK 465 LEU A 1326 REMARK 465 GLU A 1327 REMARK 465 PRO A 1328 REMARK 465 SER A 1329 REMARK 465 GLU A 1330 REMARK 465 GLY A 1404 REMARK 465 ILE A 1405 REMARK 465 LEU A 1406 REMARK 465 ASP A 1407 REMARK 465 LYS A 1408 REMARK 465 LYS A 1409 REMARK 465 PRO A 1410 REMARK 465 PRO A 1411 REMARK 465 ASP A 1464 REMARK 465 CYS A 1465 REMARK 465 PRO A 1466 REMARK 465 THR A 1467 REMARK 465 SER A 1468 REMARK 465 ASP A 1469 REMARK 465 ALA A 1470 REMARK 465 VAL A 1471 REMARK 465 ASN A 1472 REMARK 465 HIS A 1473 REMARK 465 SER A 1474 REMARK 465 LEU A 1475 REMARK 465 SER A 1476 REMARK 465 PHE A 1477 REMARK 465 ILE A 1478 REMARK 465 SER A 1479 REMARK 465 ASP A 1480 REMARK 465 GLY A 1481 REMARK 465 ASN A 1482 REMARK 465 VAL A 1483 REMARK 465 LEU A 1484 REMARK 465 ASN A 1504 REMARK 465 ARG A 1505 REMARK 465 ASP A 1506 REMARK 465 HIS A 1507 REMARK 465 LYS A 1508 REMARK 465 ALA A 1509 REMARK 465 VAL A 1510 REMARK 465 GLY A 1511 REMARK 465 ARG A 1512 REMARK 465 HIS A 1530 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1206 CG CD OE1 OE2 REMARK 470 ARG A1207 CG CD NE CZ NH1 NH2 REMARK 470 LEU A1208 CG CD1 CD2 REMARK 470 VAL A1209 CG1 CG2 REMARK 470 LEU A1211 CG CD1 CD2 REMARK 470 ASP A1217 CG OD1 OD2 REMARK 470 GLU A1220 CB CG CD OE1 OE2 REMARK 470 SER A1234 CB OG REMARK 470 ASP A1269 CB CG OD1 OD2 REMARK 470 MET A1271 CB CG SD CE REMARK 470 GLN A1272 CB CG CD OE1 NE2 REMARK 470 LYS A1283 CG CD CE NZ REMARK 470 LYS A1299 CG CD CE NZ REMARK 470 ASP A1302 CB CG OD1 OD2 REMARK 470 SER A1331 OG REMARK 470 LEU A1332 CG CD1 CD2 REMARK 470 GLU A1333 CG CD OE1 OE2 REMARK 470 GLU A1334 CG CD OE1 OE2 REMARK 470 ASN A1335 CG OD1 ND2 REMARK 470 GLN A1336 CG CD OE1 NE2 REMARK 470 ARG A1337 CG CD NE CZ NH1 NH2 REMARK 470 ASN A1338 CG OD1 ND2 REMARK 470 LYS A1345 CG CD CE NZ REMARK 470 GLN A1378 CG CD OE1 NE2 REMARK 470 ASN A1379 CG OD1 ND2 REMARK 470 TYR A1401 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A1402 CG CD OE1 OE2 REMARK 470 PRO A1412 CG CD REMARK 470 ILE A1414 CG1 CG2 CD1 REMARK 470 GLU A1415 CG CD OE1 OE2 REMARK 470 ARG A1416 CG CD NE CZ NH1 NH2 REMARK 470 PHE A1446 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE A1451 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A1486 CG CD1 CD2 REMARK 470 HIS A1487 N REMARK 470 SER A1503 OG REMARK 470 ARG A1513 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1529 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB LEU A 1486 CA HIS A 1487 1.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU A1486 CA LEU A1486 CB 0.893 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A1486 CB - CA - C ANGL. DEV. = -80.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A1220 -25.77 124.40 REMARK 500 LEU A1221 41.71 77.45 REMARK 500 VAL A1230 -46.93 -135.99 REMARK 500 PRO A1232 127.65 -34.38 REMARK 500 GLN A1235 37.11 -84.48 REMARK 500 GLU A1264 36.04 -80.84 REMARK 500 VAL A1265 -31.32 -134.67 REMARK 500 LEU A1267 -108.55 -99.87 REMARK 500 ALA A1268 -78.26 62.42 REMARK 500 ASP A1269 67.78 77.22 REMARK 500 SER A1270 141.03 53.61 REMARK 500 MET A1271 44.64 -87.28 REMARK 500 ASN A1278 68.42 -118.61 REMARK 500 ALA A1281 -30.96 -175.04 REMARK 500 ALA A1294 32.53 -77.90 REMARK 500 THR A1295 -55.27 -130.69 REMARK 500 ASP A1302 4.63 -61.70 REMARK 500 GLU A1333 -9.76 -150.02 REMARK 500 ASN A1335 44.17 -84.04 REMARK 500 GLN A1336 -19.90 -171.06 REMARK 500 ASN A1379 -78.88 77.39 REMARK 500 SER A1380 -31.67 67.25 REMARK 500 PHE A1392 -59.91 -160.28 REMARK 500 VAL A1398 -72.08 -56.56 REMARK 500 THR A1435 -88.50 -117.24 REMARK 500 PRO A1528 -80.74 -56.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 1302 PRO A 1303 137.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A1254 0.08 SIDE CHAIN REMARK 500 TYR A1296 0.07 SIDE CHAIN REMARK 500 TYR A1524 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 1NF1 A 1198 1530 UNP P21359 NF1_HUMAN 864 1196 SEQRES 1 A 333 GLU THR VAL LEU ALA ASP ARG PHE GLU ARG LEU VAL GLU SEQRES 2 A 333 LEU VAL THR MET MET GLY ASP GLN GLY GLU LEU PRO ILE SEQRES 3 A 333 ALA MET ALA LEU ALA ASN VAL VAL PRO CYS SER GLN TRP SEQRES 4 A 333 ASP GLU LEU ALA ARG VAL LEU VAL THR LEU PHE ASP SER SEQRES 5 A 333 ARG HIS LEU LEU TYR GLN LEU LEU TRP ASN MET PHE SER SEQRES 6 A 333 LYS GLU VAL GLU LEU ALA ASP SER MET GLN THR LEU PHE SEQRES 7 A 333 ARG GLY ASN SER LEU ALA SER LYS ILE MET THR PHE CYS SEQRES 8 A 333 PHE LYS VAL TYR GLY ALA THR TYR LEU GLN LYS LEU LEU SEQRES 9 A 333 ASP PRO LEU LEU ARG ILE VAL ILE THR SER SER ASP TRP SEQRES 10 A 333 GLN HIS VAL SER PHE GLU VAL ASP PRO THR ARG LEU GLU SEQRES 11 A 333 PRO SER GLU SER LEU GLU GLU ASN GLN ARG ASN LEU LEU SEQRES 12 A 333 GLN MET THR GLU LYS PHE PHE HIS ALA ILE ILE SER SER SEQRES 13 A 333 SER SER GLU PHE PRO PRO GLN LEU ARG SER VAL CYS HIS SEQRES 14 A 333 CYS LEU TYR GLN VAL VAL SER GLN ARG PHE PRO GLN ASN SEQRES 15 A 333 SER ILE GLY ALA VAL GLY SER ALA MET PHE LEU ARG PHE SEQRES 16 A 333 ILE ASN PRO ALA ILE VAL SER PRO TYR GLU ALA GLY ILE SEQRES 17 A 333 LEU ASP LYS LYS PRO PRO PRO ILE ILE GLU ARG GLY LEU SEQRES 18 A 333 LYS LEU MET SER LYS ILE LEU GLN SER ILE ALA ASN HIS SEQRES 19 A 333 VAL LEU PHE THR LYS GLU GLU HIS MET ARG PRO PHE ASN SEQRES 20 A 333 ASP PHE VAL LYS SER ASN PHE ASP ALA ALA ARG ARG PHE SEQRES 21 A 333 PHE LEU ASP ILE ALA SER ASP CYS PRO THR SER ASP ALA SEQRES 22 A 333 VAL ASN HIS SER LEU SER PHE ILE SER ASP GLY ASN VAL SEQRES 23 A 333 LEU ALA LEU HIS ARG LEU LEU TRP ASN ASN GLN GLU LYS SEQRES 24 A 333 ILE GLY GLN TYR LEU SER SER ASN ARG ASP HIS LYS ALA SEQRES 25 A 333 VAL GLY ARG ARG PRO PHE ASP LYS MET ALA THR LEU LEU SEQRES 26 A 333 ALA TYR LEU GLY PRO PRO GLU HIS HELIX 1 1 LEU A 1208 GLY A 1216 1 9 HELIX 2 2 ALA A 1224 ALA A 1228 1 5 HELIX 3 3 CYS A 1233 ASP A 1248 5 16 HELIX 4 4 LEU A 1253 VAL A 1265 1 13 HELIX 5 5 SER A 1282 GLY A 1293 1 12 HELIX 6 6 TYR A 1296 LYS A 1299 1 4 HELIX 7 7 THR A 1343 SER A 1352 1 10 HELIX 8 8 LEU A 1361 GLN A 1374 1 14 HELIX 9 9 ILE A 1381 ARG A 1391 1 11 HELIX 10 10 ILE A 1393 VAL A 1398 1 6 HELIX 11 11 ILE A 1413 LYS A 1419 1 7 HELIX 12 12 MET A 1421 ASN A 1430 1 10 HELIX 13 13 ARG A 1441 ASP A 1460 5 20 HELIX 14 14 ARG A 1488 ASN A 1493 1 6 HELIX 15 15 LYS A 1496 GLN A 1499 1 4 HELIX 16 16 PHE A 1515 TYR A 1524 1 10 CRYST1 88.250 58.300 74.800 90.00 118.00 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011331 0.000000 0.006025 0.00000 SCALE2 0.000000 0.017153 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015141 0.00000